ENSG vs OMCL: fair value comparison
The Ensign Group, Inc. and Omnicell, Inc. · Updated 2026-08-31
ENSG currently screens as fairly valued while OMCL screens as undervalued. Within Healthcare, OMCL currently sits closer to the top of our discount ranking.
| ENSG | OMCL | |
|---|---|---|
| Verdict | Fairly valued | Undervalued |
| Last price | $177.23 | $37.65 |
| 12-month range | $164.82–$215.67 | $29.96–$48.70 |
| Sector rank | #56 of 113 Healthcare | #52 of 113 Healthcare |
| Quality grade | D | D |
| Leverage | Moderate | Low |
| RSI zone | Neutral | Oversold |
| 50/200-day trend | Mixed | Downtrend |
| 52-week position | The bottom quarter | The lower-middle quarter |
Full single-stock breakdowns: ENSG fair value analysis · OMCL fair value analysis